Aging
Navigate
Submit an Article
Research Paper|Volume 15, Issue 20|pp. 10996–11011
BTN2A2, a new biomarker and therapeutic target for glioma
Back to articleFigure 5(5 of 9)
100%
Figure 5
Figure 5.Enrichment analysis of BTN2A2 in glioma. (A–C) The GO enrichment analysis was performed on BTN2A2 using TCGA. (D) The KEGG pathway analysis of BTN2A2 using the TCGA database.
Figure 5 — BTN2A2, a new biomarker and therapeutic target for glioma | Aging